ZyVersa Therapeutics Inc (NASDAQ:ZVSA) traded at $0.85 at close of the session on Monday, March 18, made an upward move of 8.79% on its previous day’s price.
Looking at the stock we see that its previous close was $0.78 and the beta (5Y monthly) reads -0.02 . In terms of its 52-week price range, ZVSA has a high of $96.95 and a low of $0.50. The company’s stock has gained about 47.21% over that past 30 days.
ZyVersa Therapeutics Inc has a market cap of $1.39 million. Estimates by analysts give the company expected earnings per share (EPS) of -$2.14, with the EPS growth for the year raised at -$71.12 for 2023 and -$1.5 for next year.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the ZVSA stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is -0.30% off its SMA20 and 14.85% from its 50-day simple moving average. The RSI (14) is pointing at 51.59 while the volatility over the past week is 12.32% and jumps to 26.03% over the past one month. The beta value is 0.65, while the average true range (ATR) is currently pointing at 0.17.
Coming back to ZyVersa Therapeutics Inc (NASDAQ:ZVSA), we note that the average 3-month trading volume was 2.77 million, while that of the preceding 10-day period stands at 1.58 million. Current shares outstanding are 1.64 million.
The insiders hold 2.60% of the company’s shares while institutions hold 12.30%. The data shows that short shares as of Feb 29, 2024, stood at 1.19 million at a short ratio of 0.21. This represents a 25.59% short interest in shares outstanding on Feb 29, 2024. Shares short rose in February from the previous month at 0.19 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -5.66% down in year-to-date price movement.
